| 1 |
35293383 | ARL6IP5 reduces cisplatin-resistance by suppressing DNA repair and promoting apoptosis pathways in ovarian carcinoma. | 2022 Mar 15 |
1 |
| 2 |
33719846 | Baicalin attenuates XRCC1-mediated DNA repair to enhance the sensitivity of lung cancer cells to cisplatin. | 2021 Mar 15 |
5 |
| 3 |
31997432 | Prospective evaluation of XRCC-1 Arg194Trp polymorphism as bio-predictor for clinical outcome in locally advanced laryngeal cancer undergoing cisplatin-based chemoradiation. | 2020 May |
3 |
| 4 |
32243652 | Enhancing the sensitivity of the thymidine kinase assay by using DNA repair-deficient human TK6 cells. | 2020 Jul |
1 |
| 5 |
30850922 | Fibroblasts from patients with idiopathic pulmonary fibrosis are resistant to cisplatin-induced cell death via enhanced CK2-dependent XRCC1 activity. | 2019 Jun |
4 |
| 6 |
31586226 | Cisplatin ototoxicity in children: risk factors and its relationship with polymorphisms of DNA repair genes ERCC1, ERCC2, and XRCC1. | 2019 Dec |
2 |
| 7 |
29989047 | KDM5B demethylates H3K4 to recruit XRCC1 and promote chemoresistance. | 2018 |
1 |
| 8 |
28110804 | Differential role of base excision repair proteins in mediating cisplatin cytotoxicity. | 2017 Mar |
1 |
| 9 |
28332164 | Polymorphism in XRCC1 gene modulates survival and clinical outcomes of advanced North Indian lung cancer patients treated with platinum-based doublet chemotherapy. | 2017 Apr |
1 |
| 10 |
28422153 | Clinical-pharmacogenetic models for personalized cancer treatment: application to malignant mesothelioma. | 2017 Apr 19 |
1 |
| 11 |
28780472 | Different profiles of the mRNA levels of DNA repair genes in MCF-7 and SH-SY5Y cells after treatment with combination of cisplatin, 50-Hz electromagnetic field and bleomycin. | 2017 Oct |
1 |
| 12 |
27026405 | Curcumin downregulates p38 MAPK-dependent X-ray repair cross-complement group 1 (XRCC1) expression to enhance cisplatin-induced cytotoxicity in human lung cancer cells. | 2016 Jun |
10 |
| 13 |
28081275 | Role of XRCC1 gene polymorphisms in non-small cell lung cancer cisplatin-based chemotherapy, and their effect on clinical and pathological characteristics. | 2016 Dec 23 |
3 |
| 14 |
25348020 | TXNL1 induces apoptosis in cisplatin resistant human gastric cancer cell lines. | 2015 |
1 |
| 15 |
25925371 | Effects of JWA, XRCC1 and BRCA1 mRNA expression on molecular staging for personalized therapy in patients with advanced esophageal squamous cell carcinoma. | 2015 Apr 30 |
1 |
| 16 |
26033426 | Clinical outcome of cisplatin-based chemotherapy is associated with the polymorphisms of GSTP1 and XRCC1 in advanced non-small cell lung cancer patients. | 2015 Sep |
2 |
| 17 |
26097600 | Association of GSTP1 and XRCC1 gene polymorphisms with clinical outcome of advanced non-small cell lung cancer patients with cisplatin-based chemotherapy. | 2015 |
3 |
| 18 |
26309678 | Effect of APE1 and XRCC1 gene polymorphism on susceptibility to hepatocellular carcinoma and sensitivity to cisplatin. | 2015 |
3 |
| 19 |
26345972 | Association of GSTP1 and XRCC1 gene polymorphisms with clinical outcomes of patients with advanced non-small cell lung cancer. | 2015 Aug 28 |
2 |
| 20 |
26823821 | Role of GSTP1 Ile105Val and XRCC1 Arg194Trp, Arg280His and Arg399Gln gene polymorphisms in the clinical outcome of advanced non-small cell lung cancer. | 2015 |
1 |
| 21 |
24525731 | TXNL1-XRCC1 pathway regulates cisplatin-induced cell death and contributes to resistance in human gastric cancer. | 2014 Feb 13 |
8 |
| 22 |
25476899 | JWA reverses cisplatin resistance via the CK2-XRCC1 pathway in human gastric cancer cells. | 2014 Dec 4 |
10 |
| 23 |
23225521 | Clinicopathological and functional significance of XRCC1 expression in ovarian cancer. | 2013 Jun 15 |
3 |
| 24 |
22266871 | Inhibition of Gli1 results in altered c-Jun activation, inhibition of cisplatin-induced upregulation of ERCC1, XPD and XRCC1, and inhibition of platinum-DNA adduct repair. | 2012 Nov 1 |
4 |
| 25 |
21264830 | DNA repair gene polymorphisms and benefit from gefitinib in never-smokers with lung adenocarcinoma. | 2011 Jul 15 |
1 |
| 26 |
21364592 | CYP2A6 and ERCC1 polymorphisms correlate with efficacy of S-1 plus cisplatin in metastatic gastric cancer patients. | 2011 Mar 29 |
1 |
| 27 |
19853026 | Increase the cisplatin cytotoxicity and cisplatin-induced DNA damage in HepG2 cells by XRCC1 abrogation related mechanisms. | 2010 Feb 1 |
7 |
| 28 |
20331623 | BRCA1 and XRCC1 polymorphisms associated with survival in advanced gastric cancer treated with taxane and cisplatin. | 2010 May |
2 |
| 29 |
19958624 | [Correlation of the sensitivity of NP chemotherapy in non-small lung cancer with DNA repair gene XRCC1 polymorphism]. | 2009 Dec |
1 |
| 30 |
18400332 | XRCC1 polymorphisms and severe toxicity in lung cancer patients treated with cisplatin-based chemotherapy in Chinese population. | 2008 Oct |
4 |
| 31 |
15882455 | ABCC5, ERCC2, XPA and XRCC1 transcript abundance levels correlate with cisplatin chemoresistance in non-small cell lung cancer cell lines. | 2005 May 9 |
1 |
| 32 |
15301704 | [Single nucleotide polymorphisms in XRCC1 and clinical response to platin-based chemotherapy in advanced non-small cell lung cancer]. | 2004 Aug |
1 |